What have you heard about

Research, development, and utilization of molecular therapies is on the rise.

The need for these new and innovative approaches has never been more critical.

There are over 7,000 unique rare diseases; 80% are genetic in origin.


of all cancer cases are rare cancers.

Over 350 cell and gene therapies are currently in development in the U.S.

The influx of these cutting-edge therapies is creating multiple knowledge gaps throughout healthcare.

Bring in the experts who know.

At TGCA understanding the complexities of molecular therapies is in our DNA.

Through the use of appropriate, unbiased, evidence-based tools and education we work with our clients to structure novel solutions that will ultimately change more lives for the better. 

Regardless of where you fit in the care continuum, our experts can help.

Defining, Navigating, Advancing Genetic Medicine

TGCA is the only consulting firm specifically focused on helping clients develop knowledge, access data, and gain expertise to strategically navigate through the intricacies of molecular therapies.


Our Memberships

TGCA is a proud member of the following organizations:

We are here to help you.

Let’s Talk.

  • This field is for validation purposes and should be left unchanged.